Riken Vitamin Co., Ltd.

TSE:4526 Rapporto sulle azioni

Cap. di mercato: JP¥80.5b

Riken Vitamin Crescita futura

Future criteri di controllo 0/6

Riken Vitamin's earnings are forecast to decline at 0.4% per annum while its annual revenue is expected to grow at 3.5% per year. EPS is expected to grow by 1.2% per annum.

Informazioni chiave

-0.4%

Tasso di crescita degli utili

1.2%

Tasso di crescita dell'EPS

Food crescita degli utili6.1%
Tasso di crescita dei ricavi3.5%
Rendimento futuro del capitale proprion/a
Copertura analitica

Low

Ultimo aggiornamento30 Oct 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Riken Vitamin (TSE:4526) Will Pay A Dividend Of ¥40.50

Aug 28
Riken Vitamin (TSE:4526) Will Pay A Dividend Of ¥40.50

Riken Vitamin (TSE:4526) Has Announced A Dividend Of ¥40.50

Aug 13
Riken Vitamin (TSE:4526) Has Announced A Dividend Of ¥40.50

Riken Vitamin (TSE:4526) Will Pay A Dividend Of ¥40.50

Jul 26
Riken Vitamin (TSE:4526) Will Pay A Dividend Of ¥40.50

Riken Vitamin's (TSE:4526) Dividend Will Be ¥40.50

Jul 11
Riken Vitamin's (TSE:4526) Dividend Will Be ¥40.50

Riken Vitamin's (TSE:4526) Promising Earnings May Rest On Soft Foundations

May 21
Riken Vitamin's (TSE:4526) Promising Earnings May Rest On Soft Foundations

Riken Vitamin (TSE:4526) Has Announced That It Will Be Increasing Its Dividend To ¥44.50

Mar 15
Riken Vitamin (TSE:4526) Has Announced That It Will Be Increasing Its Dividend To ¥44.50

Riken Vitamin (TSE:4526) Is Increasing Its Dividend To ¥44.50

Mar 01
Riken Vitamin (TSE:4526) Is Increasing Its Dividend To ¥44.50

Previsioni di crescita degli utili e dei ricavi

TSE:4526 - Stime future degli analisti e dati finanziari passati (JPY Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
3/31/2027102,5008,820N/AN/A1
3/31/202699,3008,610N/AN/A1
3/31/202596,2008,400N/AN/A1
6/30/202492,9219,057N/AN/AN/A
3/31/202491,4848,7557,46910,451N/A
12/31/202390,5057,603N/AN/AN/A
9/30/202389,7326,9357,6889,386N/A
6/30/202389,3706,649N/AN/AN/A
3/31/202388,7506,4145,7087,835N/A
12/31/202286,9486,761N/AN/AN/A
9/30/202284,2597,5664,8097,443N/A
6/30/202281,3007,747N/AN/AN/A
3/31/202279,23121,5823,4636,823N/A
12/31/202178,20320,091N/AN/AN/A
9/30/202178,36518,4024,7787,939N/A
6/30/202178,76515,905N/AN/AN/A
3/31/202177,722-1,6183,8557,625N/A
12/31/202078,977-5,379N/AN/AN/A
9/30/202079,403-6,3121,4526,515N/A
6/30/202080,938-9,337N/AN/AN/A
3/31/202082,974-8,9334645,850N/A
12/31/201984,889-5,687N/AN/AN/A
9/30/201986,754-4,3421,1086,035N/A
6/30/201987,409362N/AN/AN/A
3/31/201989,0242,6232,7156,689N/A
12/31/201890,2544,845N/AN/AN/A
9/30/201889,9884,2842,5116,239N/A
6/30/201890,1544,210N/AN/AN/A
3/31/201889,5154,800N/A5,753N/A
12/31/201789,4743,697N/AN/AN/A
9/30/201788,4724,806N/A7,348N/A
6/30/201787,4444,169N/AN/AN/A
3/31/201787,1814,089N/A8,126N/A
12/31/201687,5234,211N/AN/AN/A
9/30/201687,0303,498N/A8,629N/A
6/30/201688,3654,433N/AN/AN/A
3/31/201688,0724,107N/A8,377N/A
12/31/201587,5744,017N/AN/AN/A
9/30/201587,5594,120N/A6,961N/A
6/30/201586,4643,956N/AN/AN/A
3/31/201585,6033,795N/A5,941N/A
12/31/201485,1763,514N/AN/AN/A
9/30/201485,4583,526N/A8,193N/A
6/30/201485,3263,409N/AN/AN/A
3/31/201485,4193,590N/A6,908N/A
12/31/201383,2563,403N/AN/AN/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: 4526's earnings are forecast to decline over the next 3 years (-0.4% per year).

Guadagni vs Mercato: 4526's earnings are forecast to decline over the next 3 years (-0.4% per year).

Guadagni ad alta crescita: 4526's earnings are forecast to decline over the next 3 years.

Ricavi vs Mercato: 4526's revenue (3.5% per year) is forecast to grow slower than the JP market (4.2% per year).

Ricavi ad alta crescita: 4526's revenue (3.5% per year) is forecast to grow slower than 20% per year.


Previsioni di crescita dell'utile per azione


Rendimento futuro del capitale proprio

ROE futuro: Insufficient data to determine if 4526's Return on Equity is forecast to be high in 3 years time


Scoprire le aziende in crescita